Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab And/or Nivolumab in Hodgkin Lymphoma.
Edgar Gonzalez-Kozlova,Hsin-Hui Huang,Opeyemi A. Jagede,Kevin Tuballes,Diane M. Del Valle,Geoffrey Kelly,Manishkumar Patel,Hui Xie,Jocelyn Harris,Kimberly Argueta,Kai Nie,Vanessa Barcessat,Radim Moravec,Jennifer Altreuter,Dzifa Y. Duose,Brad S. Kahl,Stephen M. Ansell,Joyce Yu,Ethan Cerami,James R. Lindsay,Ignacio I. Wistuba,Seunghee Kim-Schulze,Catherine S. Diefenbach,Sacha Gnjatic CANCER RESEARCH COMMUNICATIONS（2024）
AI 理解论文
溯源树
样例
